Here are three notes:
- The specific IV products are 3,000-milliliter 0.9% sodium chloride irrigation and 1,000-milliliter 5% dextrose plus 0.9% sodium chloride, according to the letter.
- This change applies both to Baxter’s direct customers and its distribution partners, though there may be a one- to two-week delay in product flow through the distribution network. Allocations for children’s hospitals and renal customers remain unchanged, as do other existing allocations for specific groups.
- According to the letter, the decision was based on the progress of remediation efforts at the North Cove facility, reallocation of capacity from other Baxter facilities and the temporary importation of specific products. Baxter also emphasized the ongoing need for conservation strategies to help manage supply levels.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
